Skip to content

Fetal myocardial deformation throughout pregnancy

Fetal myocardial deformation assessed by speckle tracking; a longitudinal cohort study in the (ab)normal pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20837
Enrollment
150
Registered
2018-04-06
Start date
2018-05-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal heart deformation fetal growth restricion fetal heart development foetaal hart en de ontwikkeling van de functie van het hart. foetale groeivertraging

Interventions

not applicable
observational study A DICOM of the fetal heart wil be performed, offline analysis and measuement of fetal heart deformation values per gestational age will be performed. these measurements do not hav
we study the normal development.

Sponsors

Máxima Medical Center, Board of Management Board of Management Máxima Medical Center (in Dutch: Raad van Bestuur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Singleton pregnancy -Age >18 years -No suspicion of congenital anomalies that coul d possibly interfere with fetal cardiac function at anomaly scan -Pregnancies complicated with gestational diabetes (GDM), Fetal growth restriction (FGR) or maternal hypertensive disease, defined as: GDM: Hyperglycemia occurring after 20 weeks gestational age. Diagnosis by 75 gram oral glucoses tolerance test; at least one elevated measurement from two measurements taken after fasting > 8 hours followed by 75 gram glucoses taken; first measurement> 7.0 mmol/l and/ or measurement after 2 hours > 7.8 mmol/l Maternal hypertensive disease, including: Pregnancy induced hypertension (PIH); systolic blood pressure >140mmHg and/ or diastolic blood pressure >90mmHg occurring after 20 weeks gestational age Pre-eclampsia (PE): hypertension as defined above and proteinuria (>300mg/24h) HELLP syndrome: combination of hemolysis (LDH >600 U/L, haptoglobin70 U/L) and low platelets (19 weeks

Exclusion criteria

Exclusion criteria: -Multiple pregnancies -Age <18 years -Suspicion of congenital anomalies that could possibly interfere with fetal cardiac function. -Fetal cardiac arrhythmia -Pre-existent maternal disease that might influence on fetal development; including diabetes mellitus, pre-existent hypertensive disease, auto-immune disease -Insufficient understanding of Dutch language

Design outcomes

Primary

MeasureTime frame
In this longitudinal cohort study, the main study parameter is the determination of normal values of fetal myocardial deformation with increasing gestation. Normal values of fetal myocardial deformation that can be obtained: Strain (%) Strain rate (1/strain) Velocity (cm/s) Dyssynchrony (ms) Sphericity index Shortening fraction (%)

Secondary

MeasureTime frame
Fetal myocardial deformation values in complicated pregnancies (i.e pregnancies complicated with gestational diabetes, fetal growth restriction, maternal hypertensive disease in pregnancy), will be compared to the values in uncomplicated pregnancies in an explorative pilot study. Inter-and intra-observer variability will be examined and limits of agreement will be assessed. Analysis of the images will be performed offline by 2 different researchers who are blinded for each other’s results. All the images will be examined twice by the same examiner, leaving 4 weeks in between the examinations so the examiner will be blinded for the first results.

Contacts

Public ContactN.H.M. van Oostrum
noortje.van.oostrum@mmc.nl+31 40 8888384

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)